Cancer Therapy and Immunogenicity of COVID Vaccine (CANNINE Trial)


Cancer Therapy and Immunogenicity of COVID Vaccine (CANNINE Trial)


Primary Investigator:
Cuncong Zhong
Funding:
$5000.00
Sponsor:
KU Medical Research Institute
Beginning Fiscal Year:
2022
Award Type:
Contract